PortfoliosLab logoPortfoliosLab logo
IBB vs. SPAQ
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

IBB vs. SPAQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Nasdaq Biotechnology ETF (IBB) and Horizon Kinetics SPAC Active ETF (SPAQ). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

IBB vs. SPAQ - Yearly Performance Comparison


2026 (YTD)202520242023
IBB
iShares Nasdaq Biotechnology ETF
0.88%27.98%-2.41%1.06%
SPAQ
Horizon Kinetics SPAC Active ETF
0.14%7.35%4.33%5.52%

Returns By Period

In the year-to-date period, IBB achieves a 0.88% return, which is significantly higher than SPAQ's 0.14% return.


IBB

1D
0.76%
1M
-2.11%
YTD
0.88%
6M
14.77%
1Y
37.04%
3Y*
9.92%
5Y*
2.62%
10Y*
6.92%

SPAQ

1D
0.09%
1M
-0.41%
YTD
0.14%
6M
1.74%
1Y
4.91%
3Y*
5.25%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


IBB vs. SPAQ - Expense Ratio Comparison

IBB has a 0.47% expense ratio, which is lower than SPAQ's 0.85% expense ratio.


Return for Risk

IBB vs. SPAQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBB
IBB Risk / Return Rank: 8181
Overall Rank
IBB Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
IBB Sortino Ratio Rank: 8181
Sortino Ratio Rank
IBB Omega Ratio Rank: 7373
Omega Ratio Rank
IBB Calmar Ratio Rank: 8888
Calmar Ratio Rank
IBB Martin Ratio Rank: 8585
Martin Ratio Rank

SPAQ
SPAQ Risk / Return Rank: 3030
Overall Rank
SPAQ Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
SPAQ Sortino Ratio Rank: 2727
Sortino Ratio Rank
SPAQ Omega Ratio Rank: 2929
Omega Ratio Rank
SPAQ Calmar Ratio Rank: 3333
Calmar Ratio Rank
SPAQ Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBB vs. SPAQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and Horizon Kinetics SPAC Active ETF (SPAQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IBBSPAQDifference

Sharpe ratio

Return per unit of total volatility

1.56

0.57

+0.99

Sortino ratio

Return per unit of downside risk

2.16

0.85

+1.31

Omega ratio

Gain probability vs. loss probability

1.28

1.13

+0.15

Calmar ratio

Return relative to maximum drawdown

2.86

0.93

+1.94

Martin ratio

Return relative to average drawdown

10.20

3.46

+6.73

IBB vs. SPAQ - Sharpe Ratio Comparison

The current IBB Sharpe Ratio is 1.56, which is higher than the SPAQ Sharpe Ratio of 0.57. The chart below compares the historical Sharpe Ratios of IBB and SPAQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


IBBSPAQDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.56

0.57

+0.99

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.12

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.30

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

0.78

-0.52

Correlation

The correlation between IBB and SPAQ is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

IBB vs. SPAQ - Dividend Comparison

IBB's dividend yield for the trailing twelve months is around 0.23%, less than SPAQ's 16.66% yield.


TTM20252024202320222021202020192018201720162015
IBB
iShares Nasdaq Biotechnology ETF
0.23%0.23%0.29%0.26%0.31%0.21%0.21%0.33%0.20%0.30%0.19%0.03%
SPAQ
Horizon Kinetics SPAC Active ETF
16.66%16.69%3.00%2.60%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

IBB vs. SPAQ - Drawdown Comparison

The maximum IBB drawdown since its inception was -62.85%, which is greater than SPAQ's maximum drawdown of -5.30%. Use the drawdown chart below to compare losses from any high point for IBB and SPAQ.


Loading graphics...

Drawdown Indicators


IBBSPAQDifference

Max Drawdown

Largest peak-to-trough decline

-62.85%

-5.30%

-57.55%

Max Drawdown (1Y)

Largest decline over 1 year

-11.65%

-5.30%

-6.35%

Max Drawdown (5Y)

Largest decline over 5 years

-39.82%

Max Drawdown (10Y)

Largest decline over 10 years

-39.82%

Current Drawdown

Current decline from peak

-4.16%

-1.89%

-2.27%

Average Drawdown

Average peak-to-trough decline

-21.30%

-0.53%

-20.77%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.27%

1.42%

+1.85%

Volatility

IBB vs. SPAQ - Volatility Comparison

iShares Nasdaq Biotechnology ETF (IBB) has a higher volatility of 8.38% compared to Horizon Kinetics SPAC Active ETF (SPAQ) at 1.75%. This indicates that IBB's price experiences larger fluctuations and is considered to be riskier than SPAQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


IBBSPAQDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.38%

1.75%

+6.63%

Volatility (6M)

Calculated over the trailing 6-month period

14.50%

6.21%

+8.29%

Volatility (1Y)

Calculated over the trailing 1-year period

24.01%

8.59%

+15.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.87%

7.04%

+14.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.37%

7.04%

+16.33%